UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000015554
Receipt number R000018007
Scientific Title A study on the effects of culture supernatant of human somatic stem cells on diabetes mellitus
Date of disclosure of the study information 2014/10/28
Last modified on 2019/05/03 20:21:45

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A study on the effects of culture supernatant of human somatic stem cells on diabetes mellitus

Acronym

The effects of culture supernatant of human stem cells on diabetes mellitus

Scientific Title

A study on the effects of culture supernatant of human somatic stem cells on diabetes mellitus

Scientific Title:Acronym

The effects of culture supernatant of human stem cells on diabetes mellitus

Region

Japan


Condition

Condition

Diabetes mellitus

Classification by specialty

Medicine in general Endocrinology and Metabolism

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Evaluation of the safety and efficacy of culture supernatant of human somatic stem cells on diabetes mellitus

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Safety: Adverse events and laboratory tests

Key secondary outcomes

Efficacy: Clinical symptoms and laboratory tests


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Intravenous or intranasal administration of culture supernatant of human somatic stem cells

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients with diabetes mellitus under treatment
Treatment has not been changed in the previous month and it is anticipated that the treatment will not be changed in the next month
Patients with abnormal HbA1c

Key exclusion criteria

Patients with malignant diseases

Target sample size

6


Research contact person

Name of lead principal investigator

1st name Megumu
Middle name
Last name Kanno

Organization

Southern TOHOKU General Hospital

Division name

Cardiovascular Center

Zip code

963-8563

Address

7-115 Yatsuyamada, Koriyama, Fukushima, 963-8563, Japan

TEL

024-934-5322

Email

m.kanno@mt.strins.or.jp


Public contact

Name of contact person

1st name Hiroshi
Middle name
Last name Terunuma

Organization

Southern TOHOKU Research Institute for Neuroscience

Division name

Clinical research center for regeneration factor

Zip code

963-8563

Address

7-115 Yatsuyamada, Koriyama, Fukushima, 963-8563, Japan

TEL

024-934-5322

Homepage URL


Email

terunuma.h@gmail.com


Sponsor or person

Institute

Southern TOHOKU General Hospital

Institute

Department

Personal name



Funding Source

Organization

Quarrymen Co., Ltd

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Southern Tohoku General Hospital IRB

Address

7-115 Hachiyamada, Koriyama, Fukushima

Tel

024-934-5322

Email

yousuke.mizuno@mt.strins.or.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

総合南東北病院(福島県)


Other administrative information

Date of disclosure of the study information

2014 Year 10 Month 28 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2013 Year 11 Month 13 Day

Date of IRB

2013 Year 11 Month 13 Day

Anticipated trial start date

2014 Year 06 Month 01 Day

Last follow-up date

2015 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2014 Year 10 Month 28 Day

Last modified on

2019 Year 05 Month 03 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000018007


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name